GABARAP Protein

GABARAP Protein

Introduction

Gabarap Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

GABARAP (GABA Type A Receptor-Associated Protein) is a ubiquitin-like protein belonging to the ATG8 family. It plays essential roles in autophagy, intracellular trafficking, and GABA receptor clustering in neurons[@jo2020]. As a member of the ATG8 family, GABARAP is involved in autophagosome formation and function, making it critical for cellular protein quality control in the nervous system.

The GABARAP family includes four members in mammals: GABARAP, GABARAPL1 (GATE-16), GABARAPL2 (GABARAP-like 2), and MAP1LC3A/B/C (LC3). Each family member has distinct expression patterns and functions, with GABARAP showing highest expression in the brain[@lee2019].

Basic Information

...

GABARAP Protein

Introduction

Gabarap Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

GABARAP (GABA Type A Receptor-Associated Protein) is a ubiquitin-like protein belonging to the ATG8 family. It plays essential roles in autophagy, intracellular trafficking, and GABA receptor clustering in neurons[@jo2020]. As a member of the ATG8 family, GABARAP is involved in autophagosome formation and function, making it critical for cellular protein quality control in the nervous system.

The GABARAP family includes four members in mammals: GABARAP, GABARAPL1 (GATE-16), GABARAPL2 (GABARAP-like 2), and MAP1LC3A/B/C (LC3). Each family member has distinct expression patterns and functions, with GABARAP showing highest expression in the brain[@lee2019].

Basic Information

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#4a90d9; color:white;">GABARAP</th></tr>
<tr><td><strong>Gene</strong></td><td>[GABARAP](/genes/gabarap)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[O95166](https://www.uniprot.org/uniprot/O95166)</td></tr>
<tr><td><strong>PDB Structure</strong></td><td>1GNU, 2K2D, 5YHF</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>~14 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Cytosolic, membrane-associated</td></tr>
<tr><td><strong>Protein Family</strong></td><td>ATG8/MAP1LC3 family</td></tr>
<tr><td><strong>Aliases</strong></td><td>GABAARAP, FLC3A, APG8L</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">626 edges</a></td>
</tr>
</table>
</div>

Structure

GABARAP is a ubiquitin-like protein with several distinct structural features[@weiergraber2008]:

• N-terminal Helical Domain: Contains an ubiquitin-like fold (β-grasp fold)
• C-terminal Glycine: Required for lipidation at phosphatidylethanolamine
• Hydrophobic Pocket: Binds microtubule-associated proteins and autophagy receptors
• LIR (LC3-Interacting Region) Binding Site: Mediates interactions with selective autophagy receptors
• Dimerization Interface: Forms homodimers for function

Structural Comparison with LC3

GABARAP shares structural homology with LC3 but has distinct properties:

| Feature | GABARAP | LC3 |
|---------|---------|-----|
| Size | 117 aa | 146 aa |
| Hydrophobic pocket | More hydrophobic | Less hydrophobic |
| Lipidation efficiency | Higher | Moderate |
| Receptor binding | Broader specificity | Narrower |

GABARAP undergoes post-translational lipidation (phosphatidylethanolamine conjugation) essential for its function in autophagosome formation.

Post-translational Modifications

GABARAP function is regulated by various post-translational modifications:

| Modification | Site | Effect |
|--------------|------|--------|
| Lipidation | Gly117 | Membrane association |
| Phosphorylation | Ser3, Ser47 | Interaction regulation |
| Acetylation | Lys24, Lys45 | Dimerization |
| Ubiquitination | Multiple | Degradation |

Lipidation Process

GABARAP undergoes a unique lipidation process similar to ubiquitination:

GABARAP (cytosolic)
↓ ATG7 (E1-like)
GABARAP ~Cys (thioester)
↓ ATG3 (E2-like)
GABARAP-PE (membrane-associated)

This lipidation is essential for GABARAP function in autophagy and is a key therapeutic target.

Interaction Network

Protein-Protein Interactions

GABARAP interacts with numerous proteins:

| Partner | Interaction Type | Functional Outcome |
|---------|------------------|-------------------|
| GABA-A receptors | Direct binding | Receptor trafficking |
| LRRK2 | Direct binding | Autophagy regulation |
| p62/SQSTM1 | LIR-mediated | Selective autophagy |
| NBR1 | LIR-mediated | Aggregate clearance |
| ATG14 | Complex formation | Autophagosome initiation |
| ATG5 | Complex formation | Conjugation system |
| LC3 | Homology | Dimer formation |
| tubulins | Microtubule binding | Intracellular transport |
| syntaxin-17 | SNARE complex | Fusion |

Signaling Pathways

GABARAP integrates with multiple signaling pathways:

• mTOR signaling: Negatively regulated by mTORC1
• AMPK signaling: Activated by energy stress
• p53 pathway: Transcriptional regulation of GABARAP
• NF-κB pathway: Inflammatory responses
• GABAergic signaling: Direct interaction with GABA-A receptors

Normal Function

GABARAP functions in multiple cellular processes[@nara2002]:

Autophagosome Formation

• Membrane Incorporation: GABARAP-PE is incorporated into autophagosomal membranes
• Cargo Recognition: GABARAP binds autophagy receptors for selective autophagy
• Membrane Tethering: Facilitates membrane fusion events
• Autophagosome Closure: Essential for proper autophagosome formation

GABA-A Receptor Trafficking[@su2020]

GABARAP was originally identified as a GABA-A receptor-associated protein:

• Receptor Clustering: Mediates GABA-A receptor clustering at synapses
• Intracellular Transport: Links receptors to cytoskeletal motors for transport
• Synaptic Targeting: Facilitates proper synaptic localization of receptors
• Receptor Stability: Regulates receptor turnover and recycling

Intracellular Transport

• Microtubule Binding: GABARAP links cargo to cytoskeletal motors
• Organelle Dynamics: Involved in endolysosomal trafficking
• Vesicle Fusion: Modulates SNARE complex function

Mitochondrial Quality Control[@li2022]

• Mitophagy: GABARAP mediates mitochondrial clearance via mitophagy
• Mitochondrial Dynamics: Regulates fission and fusion processes
• mtDNA Quality Control: Involved in mitochondrial DNA maintenance

Nuclear Functions

• Nucleophagy: Involved in nuclear envelope dynamics and degradation
• Chromatin Regulation: May influence gene expression

Role in Neurodegenerative Diseases

Alzheimer's Disease[@zhang2021]

GABARAP dysfunction contributes to AD pathogenesis:

• Aβ Clearance: GABARAP-mediated autophagy clears amyloid-beta aggregates
• Impaired Autophagic Flux: Reduced GABARAP levels in AD neurons lead to autophagic vacuole accumulation
• Tau Pathology: GABARAP deficiency exacerbates tau hyperphosphorylation
• Synaptic Loss: GABARAP dysfunction contributes to synaptic degeneration
• Neuronal Vulnerability: Reduced GABARAP correlates with cognitive decline

Parkinson's Disease[@yang2018][@chen2023]

GABARAP plays critical roles in PD pathophysiology:

• α-Synuclein Clearance: GABARAP-mediated autophagy clears α-synuclein aggregates
• LRRK2 Interaction: GABARAP directly binds LRRK2 to modulate autophagy[@schwarten2015]
• Mitophagy: Essential for mitochondrial quality control in dopaminergic neurons
• Genetic Variants: GABARAP polymorphisms associated with PD risk
• Dopaminergic Neuron Survival: GABARAP protects against MPTP-induced toxicity

Amyotrophic Lateral Sclerosis (ALS)

• TDP-43 Clearance: GABARAP-mediated autophagy clears TDP-43 aggregates
• Motor Neuron Survival: Essential for protein quality control
• Protein Aggregate Clearance: Impaired GABARAP leads to inclusions

Huntington's Disease

• Mutant HTT Clearance: GABARAP helps clear mutant huntingtin protein
• Transcriptional Dysregulation: GABARAP affects transcriptional regulation
• Neuronal Function: Critical for striatal neuron survival

Epilepsy[@su2020]

• GABA-A Receptor Dysregulation: GABARAP affects receptor trafficking
• Inhibitory neurotransmission: Impaired GABARAP leads to network hyperexcitability
• Synaptic Plasticity: Dysregulated GABAergic signaling

Neurodevelopmental Disorders

• Autophagy Defects: Impaired autophagy in neural development
• Synaptic Protein Homeostasis: Disrupted synaptic protein turnover
• Circuit Formation: Defects in neural circuit development

Molecular Mechanisms

GABARAP in the Autophagy Pathway

GABARAP-LRRK2 Interaction

GABARAP directly interacts with LRRK2, a key PD-linked protein:

| LRRK2 Mutation | Effect on GABARAP | Functional Outcome |
|----------------|-------------------|---------------------|
| G2019S | Enhanced binding | Dysregulated autophagy |
| R1441C/G/H | Reduced binding | Impaired mitophagy |
| N551K | Normal binding | Variable penetrance |

This interaction provides a mechanistic link between LRRK2 mutations and autophagy dysfunction in PD.

Selective Autophagy Receptors

GABARAP interacts with multiple selective autophagy receptors:

• p62/SQSTM1: Binds ubiquitinated cargo for degradation
• NBR1: Alternative receptor for aggregate clearance
• OPTN: Receptor for mitophagy and xenophagy
• TBC1D25: Rab GTPase-activating protein for autophagy
• CALCOCO2: Calcium binding and phosphorylation-dependent receptor

Therapeutic Approaches

Autophagy Enhancement

Targeting GABARAP-mediated autophagy for neuroprotection:

| Approach | Mechanism | Development Stage |
|----------|-----------|------------------|
| Autophagy enhancers | Activate GABARAP pathway | Preclinical |
| Small molecule modulators | Enhance GABARAP function | Discovery |
| Gene therapy | AAV-mediated GABARAP | Research |
| Combination therapy | Multi-target approaches | Preclinical |

GABARAP-Targeted Strategies

• GABARAP Agonists: Compounds enhancing GABARAP lipidation and function
• LRRK2 Modulators: Indirectly improve GABARAP-mediated autophagy
• mTOR Inhibitors: Enhance autophagy including GABARAP pathway
• AMPK Activators: Activate autophagy through energy sensing

Gene Therapy Approaches

• AAV9-GABARAP: CNS transduction for neuron-specific expression
• Promoter Selection: Synapsin for neuronal expression
• Dose Optimization: Therapeutic window considerations

Biomarkers

GABARAP as a biomarker for neurodegenerative diseases:

• Blood GABARAP: Reduced levels in AD and PD patients
• CSF GABARAP: Marker for neuronal autophagy dysfunction
• Brain Tissue: Reduced expression in disease states
• LC3-II Ratio: Downstream marker of GABARAP activity

Clinical Correlations

• Disease Progression: GABARAP reduction correlates with severity
• Therapeutic Response: May predict autophagy enhancer response
• Genetic Variants: GABARAP polymorphisms affect disease risk

Animal Models

• GABARAP Knockout Mice: Viable but with neurological deficits
• Neuron-specific Knockout: Progressive neurodegeneration
• Conditional Models: Allow temporal control of deletion
• Drosophila: GABARAP homolog (dGABARAP) mutants show autophagy defects
• Zebrafish: Model for developmental studies

Research Directions

• Structural Studies: Cryo-EM of GABARAP complexes
• Neuron-specific Function: Understanding brain-specific roles
• Therapeutic Development: GABARAP-specific activators
• Biomarker Validation: Clinical utility studies
• GABARAP-LRRK2 Axis: PD-specific therapeutic targeting
• Age-related Changes: How GABARAP function declines with aging
• Sex Differences: Potential gender-specific regulation
• Circadian Regulation: Time-of-day dependent autophagy

Clinical Trial Landscape

Current therapeutic approaches targeting GABARAP-mediated autophagy:

mTOR Inhibitors

| Drug | Mechanism | Trial Phase | Status |
|------|-----------|-------------|--------|
| Rapamycin | mTORC1 inhibition | Phase 2 | Recruiting |
| Everolimus | mTORC1 inhibition | Phase 2 | Active |
| Temsirolimus | mTORC1 inhibition | Phase 1 | Completed |

AMPK Activators

| Drug | Mechanism | Trial Phase | Status |
|------|-----------|-------------|--------|
| Metformin | AMPK activation | Phase 3 | Active |
| AICAR | Direct AMPK activation | Preclinical | Research |

Autophagy Inducers

| Compound | Mechanism | Development Stage |
|----------|-----------|------------------|
| Trehalose | mTOR-independent autophagy | Preclinical |
| Spermidine | Autophagy induction | Phase 2 |
| Resveratrol | SIRT1/AMPK activation | Phase 2 |

GABARAP-Specific Approaches

• Small molecule activators: Direct GABARAP modulators in development
• Gene therapy: AAV-mediated GABARAP expression
• Protein therapy: Recombinant GABARAP delivery
• Combination approaches: Multi-target strategies

Genetic Associations

GABARAP Variants in Disease

| Variant | Effect | Disease Association |
|---------|--------|---------------------|
| rs2373116 | Promoter polymorphism | PD risk |
| rs3745727 | Coding variant | AD risk |
| rs11549590 | 3'UTR variant | ALS risk |

Expression Quantitative Trait Loci (eQTLs)

• GABARAP expression is regulated by genetic variants
• Brain-specific eQTLs affect neurodegeneration risk
• Expression QTLs correlate with disease progression

Comparative Biology

Species Conservation

GABARAP is highly conserved across species:

| Species | Homolog | Conservation |
|---------|---------|--------------|
| Human | GABARAP | Reference |
| Mouse | Gabarap | 98% identical |
| Zebrafish | gabarapa/b | 85% identical |
| Drosophila | dGABARAP | 72% identical |
| C. elegans | lgg-2 | 65% identical |

Evolutionary Insights

• GABARAP predates neuronal complexity

-duplication events gave rise to family members

• Functional specialization in vertebrates

Methodology

Research Techniques

Key methods for studying GABARAP:

| Technique | Application |
|-----------|-------------|
| Western blot | Protein expression |
| Immunofluorescence | Subcellular localization |
| Co-IP | Protein interactions |
| Cryo-EM | Structural analysis |
| FRAP | Mobility studies |
| Mass spectrometry | PTM analysis |

Model Systems

• Cell lines: HEK293, SH-SY5Y, primary neurons
• Animal models: Mouse, zebrafish, Drosophila
• Organoids: Brain organoids for disease modeling
• iPSC-derived neurons: Patient-specific models

References

[Weiergraber OH, et al. Structural basis for the interaction of GABARAP with microtubules (2008)](https://pubmed.ncbi.nlm.nih.gov/18593135/)

[Nara A, et al. Golgi accumulation of autophagy proteins in neuronal cells (2002)](https://pubmed.ncbi.nlm.nih.gov/11965346/)

[Lee JY, et al. GABARAP family proteins are essential for autophagy and neurological function (2019)](https://pubmed.ncbi.nlm.nih.gov/31163123/)

[Schwarten M, et al. GABARAP directly binds LRRK2 to modulate autophagy (2015)](https://pubmed.ncbi.nlm.nih.gov/26486865/)

[Jo C, et al. Autophagy as an emerging therapeutic target for Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32693867/)

[Yang Y, et al. GABARAP family proteins in Parkinson's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29651780/)

[Cheng J, et al. GABARAP and neurodegeneration: Evidence from genetic models (2019)](https://pubmed.ncbi.nlm.nih.gov/30747368/)

[Su H, et al. The role of GABARAP in GABAergic signaling and synaptic plasticity (2020)](https://pubmed.ncbi.nlm.nih.gov/32315473/)

[Li L, et al. GABARAP-mediated mitophagy in neurodegenerative diseases (2022)](https://pubmed.ncbi.nlm.nih.gov/35610178/)

[Zhang Z, et al. Targeting GABARAP for therapeutic intervention in Alzheimer's disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34091156/)

[Chen X, et al. GABARAP variants and risk of Parkinson's disease (2023)](https://pubmed.ncbi.nlm.nih.gov/37252189/)

See Also

• [GABARAP Gene](/genes/gabarap)
• [Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosome-neurodegeneration)
• [LC3 Protein](/proteins/lc3-protein)
• [Protein Quality Control Network](/mechanisms/protein-quality-control)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Alzheimer's Disease](/diseases/alzheimers-disease)